Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA; Department of Medicine, Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Cell Host Microbe. 2022 Jun 8;30(6):863-874.e4. doi: 10.1016/j.chom.2022.05.003. Epub 2022 May 27.
Gut microbiota metabolism of dietary compounds generates a vast array of microbiome-dependent metabolites (MDMs), which are highly variable between individuals. The uremic MDMs (uMDMs) phenylacetylglutamine (PAG), p-cresol sulfate (PCS), and indoxyl sulfate (IS) accumulate during renal failure and are associated with poor outcomes. Targeted dietary interventions may reduce toxic MDM generation; however, it is unclear if inter-individual differences in diet or gut microbiome dominantly contribute to MDM variance. Here, we use a 7-day homogeneous average American diet to standardize dietary precursor availability in 21 healthy individuals. During dietary homogeneity, the coefficient of variation in PAG, PCS, and IS (primary outcome) did not decrease, nor did inter-individual variation in most identified metabolites; other microbiome metrics showed no or modest responses to the intervention. Host identity and age are dominant contributors to variability in MDMs. These results highlight the potential need to pair dietary modification with microbial therapies to control MDM profiles.
饮食化合物的肠道微生物群代谢产生大量依赖于微生物组的代谢物(MDMs),这些代谢物在个体之间差异很大。尿毒症 MDMs(uMDMs)苯乙酰谷氨酰胺(PAG)、对甲酚硫酸盐(PCS)和吲哚硫酸盐(IS)在肾功能衰竭期间积累,并与不良结局相关。靶向饮食干预可能会减少有毒 MDM 的产生;然而,尚不清楚饮食或肠道微生物组在个体间差异是否主要导致 MDM 变异。在这里,我们使用 7 天的均匀平均美国饮食来标准化 21 名健康个体的饮食前体可用性。在饮食均匀性期间,PAG、PCS 和 IS 的变异系数(主要结果)没有降低,大多数鉴定出的代谢物的个体间变异也没有降低;其他微生物组指标对干预没有反应或反应较小。宿主身份和年龄是 MDMs 变异性的主要贡献者。这些结果突出表明,可能需要将饮食改变与微生物疗法相结合,以控制 MDM 谱。